P-ISSN 2587-2400 | E-ISSN 2587-196X
Contact
EJMO Home
|
Toggle navigation
EJMO HOME
ABOUT JOURNAL
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
FOR REVIEWERS
EJMO ARCHIVE
CONTACT
EJMO Volume :
8
Issue :
3
Year :
2024
COVID-19 in EJMO
8/3
EJMO Current Issue
EJMO Archive
EJMO & Congress
Most Cited Articles
Ahead of Print
Copyright Transfer Form
ICMJE COI Form
Volume: 7 Issue: 3 - 2023
SYSTEMATIC META-ANALYSIS
Clinical Effects of Postoperative Parenteral Glutamine Dipeptide Supplementation in Surgical Intensive Care Un Patients: A Systematic Review and Meta-Analysis
Mirko Barone, Regina Frontera, Rita Vaia Liouras, Luca Serano, Massimo Ippoliti, Ivan Dell’Atti, Luigi Vetrugno, Salvatore Maurizio Maggiore, Felice Mucilli
doi:
10.14744/ejmo.2023.28229
Pages 209 - 219
(Viewed: 746)
Abstract
|
Full Text PDF
|
PDF Download
Interval Comparison of Zoledronic Acid Treatment in Patients with Metastatic Bone Disease, Is 4-Weekly or 12-Weekly More Effective?: A Systematic Review and Meta-analysis
I Gede Eka Wiratnaya, Putu Astawa, Sherly Desnita Savio, Agus Suarjaya Putra, I Gusti Agung Wiksa Astrayana, Made Arditya Dwi Yudhistira, Putu Angga Dharmayuda
doi:
10.14744/ejmo.2023.34433
Pages 220 - 226
(Viewed: 711)
Abstract
|
Full Text PDF
|
PDF Download
RESEARCH ARTICLE
Association of Serum Interleukin-6 and Interleukin-8 Levels with Clinical Benefit from Immune Checkpoint Inhibitors in Patients with Advanced Gastric Cancer
Yuan Yuan, Liang Han, Yu Feng, Xiaowu Li
doi:
10.14744/ejmo.2023.38141
Pages 227 - 231
(Viewed: 642)
Abstract
|
Full Text PDF
|
PDF Download
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Caglar Unal, Nalan Alan Selcuk, Fatih Selcuk Biricik, Ozkan Alan, Cetin Ordu, Oguzhan Selvi
doi:
10.14744/ejmo.2023.48337
Pages 232 - 242
(Viewed: 679)
Abstract
|
Full Text PDF
|
PDF Download
Association Between ABO Blood Group and Hashimoto Thyroiditis
Huseyin Kurt
doi:
10.14744/ejmo.2023.49922
Pages 243 - 256
(Viewed: 573)
Abstract
|
Full Text PDF
|
PDF Download
Advancing Screening Protocols: Investigating the Role of Alpha-Fetoprotein Supported by Turkish Ministry of Health Data in Hepatocellular Carcinoma and Germ Cell Tumors
Mustafa Mahir Ulgu, Suayip Birinci
doi:
10.14744/ejmo.2023.56385
Pages 247 - 254
(Viewed: 626)
Abstract
|
Full Text PDF
|
PDF Download
Association of COVID-19 with Features of the Peripheral Hemogram Among Cancer Patients Undergoing Chemotherapy
Jia-Yong Su, Zhen-Jie Guo, Yao-Hong Liu, Qiong-Mei Li, Yan-Jun Li, Bing-Hua Chen, Yu-Ling Zhao, Jian-Hong Zhong
doi:
10.14744/ejmo.2023.18762
Pages 255 - 264
(Viewed: 650)
Abstract
|
Full Text PDF
|
PDF Download
Short-Term Efficacy and Safety of Camrelizumab-Based Treatment for Refractory or Metastatic Oesophageal Squamous Cell Carcinoma
Yuan Yuan, Qingliang Meng, Liang Han, Yu Feng, Xiaowu Li
doi:
10.14744/ejmo.2023.42506
Pages 265 - 269
(Viewed: 579)
Abstract
|
Full Text PDF
|
PDF Download
Potential Value of the Motor Protein Family KIF as a Diagnostic & Prognostic Marker for Human Hepatocellular Carcinoma: A Prospective Research
Zhen Feng, Yong Lian, Yixuan Wang
doi:
10.14744/ejmo.2023.45210
Pages 270 - 286
(Viewed: 437)
Abstract
|
Full Text PDF
|
PDF Download
REVIEW
Macrophages in Tumor Microenvironment: From Molecular Aspects to Clinical Applications
Michele Ammendola, Silvia Curcio, Giorgio Ammerata, Maria Luposella, Caterina Battaglia, Carmelo Laface, Riccardo Memeo, Giuseppe Navarra, Giuseppe Currò, Girolamo Ranieri
doi:
10.14744/ejmo.2023.26480
Pages 201 - 208
(Viewed: 567)
Abstract
|
Full Text PDF
|
PDF Download
Time to Prioritise Quality Over Quantity in Prehabilitation Trials: A Literature Review
Wilson Jiang, Michael Solomon, Sascha Karunaratne, Paula R Beckenkamp, Kari Clifford, John Woodfield, Daniel Steffens
doi:
10.14744/ejmo.2023.14880
Pages 287 - 288
(Viewed: 684)
Abstract
|
Full Text PDF
|
PDF Download
Submit Manuscript
WEB OF SCIENCE click
Impact Factor:
2.5
Medicine, General & Internal:
Q2 146/322
SCOPUS click
CiteScoreTracker 2023:
3.6
CiteScore year 2022:
0.9
CiteScore year 2021:
0.2
Google Scholar click
Number of Articles:
315
Citations:
2587
h-index:
16
i10-index:=
26
EJMO NLM ID:
101720527
Accept Ratio :
18.2 %
Final decision avg
34 day
Quick Search
In authors and institutes
In titles and abstracts
In keywords
In all
Copyright © 2024 Eurasian Journal of Medicine and Oncology, EJMO
EJMO & EJMO